The medical diagnostics company, which specialises in cancer treatments, has closed its series A round with investors including Aeris Capital, the venture firm set up by a SAP co-founder.
Canada-based oncological medicine company GenomeDX Biosciences completed its series A funding round on Monday, having raised an undisclosed amount.
The round was co-led by Aeris Capital, the venture capital (VC) firm formed by Klaus Tschira, a co-founder of software conglomerate SAP, and Baird Venture Partners, a venture capital fund operated by Baird Private Equity. Additional participation came from VC firm CD-Venture and unnamed angel investors.
GenomeDX is the developer of diagnostic tests for cancer that work on a molecular…
